Torrent Pharmaceuticals Limited (NSE: TORNTPHARM)

Market Cap	1.15T
Revenue (ttm)	109.96B
Net Income (ttm)	17.35B
Shares Out	n/a
EPS (ttm)	51.27
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Jun 21, 2024

Volume	335,029
Open	3,456.00
Previous Close	3,482.60
Day's Range	3,376.60 - 3,502.25
52-Week Range	1,822.55 - 3,574.00
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and dermatology, diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 15,718
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: TORNTPHARM

Financial Performance

In 2023, Torrent Pharmaceuticals's revenue was 107.28 billion, an increase of 11.51% compared to the previous year's 96.20 billion. Earnings were 16.56 billion, an increase of 33.02%.